These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20529041)

  • 1. Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina.
    Stewart T; Pavlakis N; Ward M
    Intern Med J; 2010 Apr; 40(4):303-7. PubMed ID: 20529041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capecitabine cardiac toxicity presenting as effort angina: a case report.
    Lestuzzi C; Crivellari D; Rigo F; Viel E; Meneguzzo N
    J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):700-3. PubMed ID: 20093950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine induced vasospastic angina.
    Coughlin S; Das S; Lee J; Cooper J
    Int J Cardiol; 2008 Oct; 130(1):e34-6. PubMed ID: 17897740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myocardial infarction after capecitabine treatment: not always vasospasm is responsible.
    Güvenç TS; Celiker E; Ozcan KS; Ilhan E; Eren M
    Chin Med J (Engl); 2012 Sep; 125(18):3349-51. PubMed ID: 22964337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capecitabine may induce coronary artery vasospasm.
    Tsiamis E; Synetos A; Stefanadis C
    Hellenic J Cardiol; 2012; 53(4):320-3. PubMed ID: 22796820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report.
    Farina A; Malafronte C; Valsecchi MA; Achilli F
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):722-6. PubMed ID: 19584743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Fluorouracil-induced coronary vasospasm.
    Bathina JD; Yusuf SW
    J Cardiovasc Med (Hagerstown); 2010 Apr; 11(4):281-4. PubMed ID: 19561527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute coronary artery thrombosis and vasospasm following capecitabine in conjunction with oxaliplatin treatment for cancer.
    Dzaye O; Cleator S; Nihoyannopoulos P
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25246465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial coronary artery spasm as cause of capecitabine-induced tako tsubo cardiomyopathy.
    Klag T; Cantara G; Ong P; Kaufmann M; Sechtem U; Athanasiadis A
    Clin Res Cardiol; 2014 Mar; 103(3):247-50. PubMed ID: 24276117
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of capecitabine-induced coronary microspasm in a patient with rectal cancer.
    Arbea L; Coma-Canella I; Martinez-Monge R; García-Foncillas J
    World J Gastroenterol; 2007 Apr; 13(14):2135-7. PubMed ID: 17465463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular fibrillation as a likely consequence of capecitabine-induced coronary vasospasm.
    Shah NR; Shah A; Rather A
    J Oncol Pharm Pract; 2012 Mar; 18(1):132-5. PubMed ID: 21321041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary spasm induced by capecitabine mimicks ST elevation myocardial infarction.
    Scott PA; Ferchow L; Hobson A; Curzen NP
    Emerg Med J; 2008 Oct; 25(10):699-700. PubMed ID: 18843078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capecitabine-associated coronary vasospasm: a case report.
    Papadopoulos CA; Wilson H
    Emerg Med J; 2008 May; 25(5):307-9. PubMed ID: 18434478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and electrocardiography changes in patients treated with capecitabine.
    Koca D; Salman T; Unek IT; Oztop I; Ellidokuz H; Eren M; Yilmaz U
    Chemotherapy; 2011; 57(5):381-7. PubMed ID: 21997165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capecitabine-induced coronary artery vasospasm in a patient who previously experienced a similar episode with fluorouracil therapy.
    Karakulak UN; Aladağ E; Maharjan N; Övünç K
    Turk Kardiyol Dern Ars; 2016 Jan; 44(1):71-4. PubMed ID: 26875134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capecitabine cardiotoxicity--case reports and literature review.
    Manojlovic N; Babic D; Stojanovic S; Filipovic I; Radoje D
    Hepatogastroenterology; 2008; 55(85):1249-56. PubMed ID: 18795667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common etiology of capecitabine and fluorouracil-induced coronary vasospasm in a colon cancer patient.
    Aksoy S; Karaca B; Dinçer M; Yalçin S
    Ann Pharmacother; 2005 Mar; 39(3):573-4. PubMed ID: 15701780
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute coronary syndrome in a patient previously treated with capecitabine and 5-fluorouracil].
    Díez Martínez AM; Navarro Martínez A; Sáez Méndez L; Valladolid Walsh A
    Farm Hosp; 2005; 29(4):295-6. PubMed ID: 16268749
    [No Abstract]   [Full Text] [Related]  

  • 19. Bolus 5-fluorouracil as an alternative in patients with cardiotoxicity associated with infusion 5-fluorouracil and capecitabine: a case series.
    Saif MW; Garcon MC; Rodriguez G; Rodriguez T
    In Vivo; 2013; 27(4):531-4. PubMed ID: 23812226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery spasm induced by capecitabine.
    Sestito A; Sgueglia GA; Pozzo C; Cassano A; Barone C; Crea F; Lanza GA
    J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):136-8. PubMed ID: 16645374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.